Literature DB >> 9261393

Repeated emergence of epidemic/epizootic Venezuelan equine encephalitis from a single genotype of enzootic subtype ID virus.

A M Powers1, M S Oberste, A C Brault, R Rico-Hesse, S M Schmura, J F Smith, W Kang, W P Sweeney, S C Weaver.   

Abstract

Venezuelan equine encephalitis (VEE) epidemics and equine epizootics occurred periodically in the Americas from the 1920s until the early 1970s, when the causative viruses, subtypes IAB and IC, were postulated to have become extinct. Recent outbreaks in Columbia and Venezuela have renewed interest in the source of epidemic/epizootic viruses and their mechanism of interepizootic maintenance. We performed phylogenetic analyses of VEE virus isolates spanning the entire temporal and geographic range of strains available, using 857-nucleotide reverse transcription-PCR products including the E3 and E2 genes. Analyses indicated that epidemic/epizootic viruses are closely related to four distinct, enzootic subtype ID-like lineages. One of these lineages, which occurs in Columbia, Peru, and Venezuela, also included all of the epidemic/epizootic isolates; the remaining three ID-like lineages, which occur in Panama, Peru, Florida, coastal Ecuador, and southwestern Columbia, were apparently not associated with epizootic VEE emergence. Within the Columbia/Peru/Venezuela lineage, three distinct monophyletic groups of epidemic/epizootic viruses were delineated, indicating that VEE emergence has occurred independently at least three times (convergent evolution). Representative, complete E2 amino acid sequences were compared to identify potential determinants of equine virulence and epizootic emergence. Amino acids implicated previously in laboratory mouse attenuation generally did not vary among the natural isolates that we examined, indicating that they probably are not involved in equine virulence changes associated with VEE emergence. Most informative amino acids correlated with phylogenetic relationships rather than phenotypic characteristics, suggesting that VEE emergence has resulted from several distinct combinations of mutations that generate viruses with similar antigenic and equine virulence phenotypes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9261393      PMCID: PMC191949     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Genetic variation of Venezuelan equine encephalitis virus strains of the ID variety in Colombia.

Authors:  R Rico-Hesse; J T Roehrig; D W Trent; R W Dickerman
Journal:  Am J Trop Med Hyg       Date:  1988-01       Impact factor: 2.345

2.  Monoclonal antibodies define antigenic variation in the ID variety of Venezuelan equine encephalitis virus.

Authors:  R Rico-Hesse; J T Roehrig; R W Dickerman
Journal:  Am J Trop Med Hyg       Date:  1988-01       Impact factor: 2.345

3.  Determination of the protective epitopes on the glycoproteins of Venezuelan equine encephalomyelitis virus by passive transfer of monoclonal antibodies.

Authors:  J H Mathews; J T Roehrig
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

4.  Antigenic analysis of the surface glycoproteins of a Venezuelan equine encephalomyelitis virus (TC-83) using monoclonal antibodies.

Authors:  J T Roehrig; J W Day; R M Kinney
Journal:  Virology       Date:  1982-04-30       Impact factor: 3.616

5.  Variants of Venezuelan equine encephalitis virus that resist neutralization define a domain of the E2 glycoprotein.

Authors:  B J Johnson; J R Brubaker; J T Roehrig; D W Trent
Journal:  Virology       Date:  1990-08       Impact factor: 3.616

6.  Molecular evolution of eastern equine encephalomyelitis virus in North America.

Authors:  S C Weaver; T W Scott; R Rico-Hesse
Journal:  Virology       Date:  1991-06       Impact factor: 3.616

7.  Recombinant vaccinia virus/Venezuelan equine encephalitis (VEE) virus protects mice from peripheral VEE virus challenge.

Authors:  R M Kinney; J J Esposito; J H Mathews; B J Johnson; J T Roehrig; A D Barrett; D W Trent
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

8.  Arbovirus studies in the Guajira region of Venezuela: activities of eastern equine encephalitis and Venezuelan equine encephalitis viruses during an interepizootic period.

Authors:  R Walder; O M Suarez; C H Calisher
Journal:  Am J Trop Med Hyg       Date:  1984-07       Impact factor: 2.345

9.  The neutralization site on the E2 glycoprotein of Venezuelan equine encephalomyelitis (TC-83) virus is composed of multiple conformationally stable epitopes.

Authors:  J T Roehrig; J H Mathews
Journal:  Virology       Date:  1985-04-30       Impact factor: 3.616

10.  The full-length nucleotide sequences of the virulent Trinidad donkey strain of Venezuelan equine encephalitis virus and its attenuated vaccine derivative, strain TC-83.

Authors:  R M Kinney; B J Johnson; J B Welch; K R Tsuchiya; D W Trent
Journal:  Virology       Date:  1989-05       Impact factor: 3.616

View more
  42 in total

1.  Development of reverse transcription-PCR assays specific for detection of equine encephalitis viruses.

Authors:  B Linssen; R M Kinney; P Aguilar; K L Russell; D M Watts; O R Kaaden; M Pfeffer
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

2.  Evolutionary relationships and systematics of the alphaviruses.

Authors:  A M Powers; A C Brault; Y Shirako; E G Strauss; W Kang; J H Strauss; S C Weaver
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

3.  Potential sources of the 1995 Venezuelan equine encephalitis subtype IC epidemic.

Authors:  A C Brault; A M Powers; G Medina; E Wang; W Kang; R A Salas; J De Siger; S C Weaver
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

4.  Reverse transcription-PCR-enzyme-linked immunosorbent assay for rapid detection and differentiation of alphavirus infections.

Authors:  Eryu Wang; Slobodan Paessler; Patricia V Aguilar; Anne-Sophie Carrara; Haolin Ni; Ivorlyne P Greene; Scott C Weaver
Journal:  J Clin Microbiol       Date:  2006-09-06       Impact factor: 5.948

5.  Envelope glycoprotein mutations mediate equine amplification and virulence of epizootic venezuelan equine encephalitis virus.

Authors:  Ivorlyne P Greene; Slobodan Paessler; Laura Austgen; Michael Anishchenko; Aaron C Brault; Richard A Bowen; Scott C Weaver
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

6.  Venezuelan equine encephalitis in Panama: fatal endemic disease and genetic diversity of etiologic viral strains.

Authors:  Evelia Quiroz; Patricia V Aguilar; Julio Cisneros; Robert B Tesh; Scott C Weaver
Journal:  PLoS Negl Trop Dis       Date:  2009-06-30

7.  Genetic characterization of Venezuelan equine encephalitis virus from Bolivia, Ecuador and Peru: identification of a new subtype ID lineage.

Authors:  Patricia V Aguilar; A Paige Adams; Victor Suárez; Luis Beingolea; Jorge Vargas; Stephen Manock; Juan Freire; Willan R Espinoza; Vidal Felices; Ana Diaz; Xiaodong Liang; Yelin Roca; Scott C Weaver; Tadeusz J Kochel
Journal:  PLoS Negl Trop Dis       Date:  2009-09-15

8.  Venezuelan equine encephalitis emergence: enhanced vector infection from a single amino acid substitution in the envelope glycoprotein.

Authors:  Aaron C Brault; Ann M Powers; Diana Ortiz; Jose G Estrada-Franco; Roberto Navarro-Lopez; Scott C Weaver
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-26       Impact factor: 11.205

9.  Venezuelan equine encephalitis virus infection of cotton rats.

Authors:  Anne-Sophie Carrara; Lark L Coffey; Patricia V Aguilar; Abelardo C Moncayo; Amelia P A Travassos Da Rosa; Marcio R T Nunes; Robert B Tesh; Scott C Weaver
Journal:  Emerg Infect Dis       Date:  2007-08       Impact factor: 6.883

10.  Natural enzootic vectors of Venezuelan equine encephalitis virus, Magdalena Valley, Colombia.

Authors:  Cristina Ferro; Jorge Boshell; Abelardo C Moncayo; Marta Gonzalez; Marta L Ahumada; Wenli Kang; Scott C Weaver
Journal:  Emerg Infect Dis       Date:  2003-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.